Portage Biotech Inc. (PRTG)
NASDAQ: PRTG · Real-Time Price · USD
5.01
-0.57 (-10.22%)
Nov 4, 2024, 4:00 PM EST - Market closed
Portage Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Nov '24 Nov 4, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Market Capitalization | 5 | 11 | 54 | 88 | 338 | 100 | |
Market Cap Growth | -93.10% | -79.28% | -38.67% | -74.06% | 238.01% | 223.81% | |
Enterprise Value | 2 | 5 | 40 | 108 | 382 | 150 | |
Last Close Price | 5.58 | 11.27 | 61.80 | 131.40 | 559.40 | 182.00 | |
PE Ratio | - | -0.14 | -0.48 | -5.09 | -20.72 | -18.57 | |
PB Ratio | 2.33 | 3.35 | 0.71 | 0.53 | 2.29 | 0.69 | |
P/FCF Ratio | -0.34 | -0.78 | -4.45 | -12.96 | -78.89 | -26.92 | |
P/OCF Ratio | -0.34 | -0.78 | -4.45 | -12.96 | -78.89 | -26.92 | |
EV/EBITDA Ratio | 0.10 | -0.30 | -2.54 | - | - | - | |
EV/EBIT Ratio | 0.10 | -0.30 | -2.54 | -6.92 | -31.18 | -25.06 | |
EV/FCF Ratio | 0.12 | -0.38 | -3.31 | -15.94 | -89.09 | -40.34 | |
Debt / Equity Ratio | 0.02 | 0.01 | - | - | 0.00 | 0.03 | |
Debt / FCF Ratio | 0.00 | 0.00 | - | - | -0.04 | -1.25 | |
Quick Ratio | 1.12 | 1.76 | 5.78 | 30.09 | 1.08 | 1.47 | |
Current Ratio | 1.73 | 2.67 | 7.33 | 31.71 | 1.54 | 1.48 | |
Return on Equity (ROE) | -191.03% | -191.51% | -86.92% | -12.25% | -11.72% | -4.93% | |
Return on Assets (ROA) | -19.41% | -21.34% | -6.71% | -5.27% | -4.40% | -2.15% | |
Return on Capital (ROIC) | -26.89% | -28.97% | -8.19% | -6.22% | -5.13% | -2.47% | |
Earnings Yield | -1214.54% | -676.02% | -194.53% | -19.24% | -4.68% | -5.33% | |
FCF Yield | -214.11% | -128.29% | -22.46% | -7.71% | -1.27% | -3.71% | |
Buyback Yield / Dilution | -17.18% | -20.00% | -23.42% | -11.31% | -7.13% | -127.22% | |
Total Shareholder Return | -17.18% | -20.00% | -23.42% | -11.31% | -7.13% | -127.22% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.